Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia.

Tran, Nikki N; Mynatt, Ryan P; Kaye, Keith S; Zhao, Jing J; Pogue, Jason M

Tran, Nikki N; Mynatt, Ryan P; Kaye, Keith S; Zhao, Jing J; Pogue, Jason M.

Afiliação

Tran NN; Department of Pharmacy Services, The Ohio State University Wexner Medical Center-The James Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA.
Mynatt RP; Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, Kentucky, USA.
Kaye KS; Department of Medicine, Division of Allergy, Immunology and Infectious Diseases, Rutgers, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
Zhao JJ; Department of Pharmacy, Harper University Hospital, Detroit Medical Center, Detroit, Michigan, USA.
Pogue JM; Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.

Open Forum Infect Dis ; 10(4): ofad170, 2023 Apr.

Article em En | MEDLINE | ID: mdl-37125229

Palavras-chave

Gram-negative bacteremia; beta-lactams; extended infusion; pharmacokinetic/pharmacodynamic

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google